Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors

被引:0
|
作者
Yoshinori Hayashi
Tomoki Makino
Eiichi Sato
Kenji Ohshima
Yuya Nogi
Takashi Kanemura
Keiichiro Honma
Kotaro Yamashita
Takuro Saito
Koji Tanaka
Kazuyoshi Yamamoto
Tsuyoshi Takahashi
Yukinori Kurokawa
Hiroshi Miyata
Kiyokazu Nakajima
Hisashi Wada
Eiichi Morii
Hidetoshi Eguchi
Yuichiro Doki
机构
[1] Osaka University,Department of Gastroenterological Surgery, Graduate School of Medicine
[2] Osaka University,Department of Clinical Research in Tumor Immunology, Graduate School of Medicine
[3] Tokyo Medical University,Department of Pathology, Institute of Medical Science (Medical Research Center)
[4] Osaka University,Department of Pathology, Graduate School of Medicine
[5] Osaka International Cancer Institute,Department of Gastroenterological Surgery
[6] Osaka International Cancer Institute,Department of Pathology
来源
British Journal of Cancer | 2023年 / 128卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2175 / 2185
页数:10
相关论文
共 50 条
  • [1] Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors
    Hayashi, Yoshinori
    Makino, Tomoki
    Sato, Eiichi
    Ohshima, Kenji
    Nogi, Yuya
    Kanemura, Takashi
    Honma, Keiichiro
    Yamashita, Kotaro
    Saito, Takuro
    Tanaka, Koji
    Yamamoto, Kazuyoshi
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Miyata, Hiroshi
    Nakajima, Kiyokazu
    Wada, Hisashi
    Morii, Eiichi
    Eguchi, Hidetoshi
    Doki, Yuichiro
    BRITISH JOURNAL OF CANCER, 2023, 128 (12) : 2175 - 2185
  • [2] Impact of tertiary lymphoid structures in response to immune checkpoint blockade in patients with head and neck squamous cell carcinoma.
    Torres, Daniel A. Ruiz
    Hirayama, Shun
    Merkin, Ross D.
    Roberts, Thomas J.
    Patel, Manisha Jayandra
    Park, Jong Chul
    Wirth, Lori J.
    Sadow, Peter
    Sade-Feldman, Moshe
    Stott, Shannon
    Faden, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma
    Liu, Zhonglong
    Meng, Xiaoyan
    Tang, Xiao
    Zou, Weili
    He, Yue
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (06) : 1505 - 1521
  • [4] Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma
    Zhonglong Liu
    Xiaoyan Meng
    Xiao Tang
    Weili Zou
    Yue He
    Cancer Immunology, Immunotherapy, 2023, 72 : 1505 - 1521
  • [5] The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma
    Ling, Yihong
    Zhong, Jian
    Weng, Zelin
    Lin, Guangrong
    Liu, Caixia
    Pan, Chuqing
    Yang, Hong
    Wei, Xiaolong
    Xie, Xiuying
    Wei, Xiaoli
    Zhang, Huizhong
    Wang, Geng
    Fu, Jianhua
    Wen, Jing
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (10):
  • [6] Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma
    Ruiz-Torres, Daniel A.
    Bryan, Michael E.
    Hirayama, Shun
    Merkin, Ross D.
    Luciani, Evelyn
    Roberts, Thomas J.
    Patel, Manisha
    Park, Jong C.
    Wirth, Lori J.
    Sadow, Peter M.
    Sade-Feldman, Moshe
    Stott, Shannon L.
    Faden, Daniel L.
    ONCOIMMUNOLOGY, 2025, 14 (01):
  • [7] Tertiary Lymphoid Structures Gene Signature Predicts Prognosis and Immune Infiltration Analysis in Head and Neck Squamous Cell Carcinoma
    Xing, Aiyan
    Lv, Dongxiao
    Wu, Changshun
    Zhou, Kai
    Zhao, Tianhui
    Zhao, Lihua
    Wang, Huaqing
    Feng, Hong
    CURRENT GENOMICS, 2024, 25 (02) : 88 - 104
  • [8] Immune checkpoint inhibitors in sinonasal squamous cell carcinoma
    Park, Jong Chul
    Faquin, William C.
    Durbeck, Julia
    Faden, Daniel L.
    ORAL ONCOLOGY, 2020, 109
  • [9] Immune checkpoint inhibitors in the treatment of oesophageal squamous cell carcinoma: where are we and where are we going?
    Chen, Ning
    Xu, Xiaoling
    Fan, Yun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [10] Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
    Oliva, M.
    Spreafico, A.
    Taberna, M.
    Alemany, L.
    Coburn, B.
    Mesia, R.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2019, 30 (01) : 57 - 67